RxDoctor Payments Data

Samantha Pankey

Physician Assistant · Frankenmuth, MINPI 1275290017

Payments from drug & device makers

$2,766in general payments, 2019–2025

Across 153 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$427
  • AstraZeneca$341
  • AbbVie$243
  • Lilly USA, LLC$216
  • Pfizer$207
  • GSK$195
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,766100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,766 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban159$222,460
MounjaroTirzepatide138$180,141
OzempicSemaglutide94$147,508
TrulicityDulaglutide65$109,014
Trelegy ElliptaFluticasone/Umeclidin/Vilanter81$67,217
JardianceEmpagliflozin50$65,987
XareltoRivaroxaban33$40,671
CaplytaLumateperone Tosylate13$24,910
JanuviaSitagliptin Phosphate16$24,822
MyrbetriqMirabegron25$22,861
Repatha SureclickEvolocumab11$16,455
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$14,988
FarxigaDapagliflozin Propanediol12$14,173
Breo ElliptaFluticasone/Vilanterol26$13,912
Mirabegron ErMirabegron15$13,528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$216$289,154203 claims
PfizerEliquis, Paxlovid$207$226,597172 claims
Novo NordiskOzempic$427$147,50894 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$195$93,146123 claims
Boehringer IngelheimJardiance$47$65,98750 claims
Johnson & JohnsonXarelto$27$40,67133 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$76$24,91013 claims
Astellas Pharma US IncMyrbetriq$141$22,86125 claims
AstraZenecaFarxiga, Symbicort$341$17,27624 claims
AbbVieLinzess$243$9,46217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Frankenmuth

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →